Kindred Biosciences to Announce Third Quarter 2020 Financial Results

Rhea-AI Summary

Kindred Biosciences, a biopharmaceutical company focusing on pet medications, will release its Q3 2020 financial results on November 9, 2020, after market close. A conference call will be held at 4:30 p.m. ET, which can be accessed via phone or a live webcast. The company aims to develop safe and effective treatments for pets, leveraging successful human-target therapeutics.

Positive

• The company is set to announce its Q3 2020 financial results, indicating ongoing operations.
• Kindred Biosciences focuses on developing innovative biologics for pets, potentially leading to market growth.

Negative

• None.

SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will release its third quarter 2020 financial results on November 9, 2020, after the market close. The Company will host a conference call at 4:30 p.m. Eastern time/1:30 p.m. Pacific time that day.

Access the call by dialing toll-free (855) 433-0927 from the U.S. or (484) 756-4262 internationally, and using conference ID 5758359.

The call will also be webcast live here, with a replay available at that link for 30 days.

About Kindred Biosciences
Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.

For more information, visit: www.kindredbio.com

Contact
Katja Buhrer 
katja.buhrer@kindredbio.com 
(917) 969-3438

View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-announce-third-quarter-2020-financial-results-301162081.html

SOURCE Kindred Biosciences, Inc.

FAQ

When will Kindred Biosciences announce its Q3 2020 earnings?

Kindred Biosciences will announce its Q3 2020 financial results on November 9, 2020, after market close.

What time is the Kindred Biosciences earnings call?

The earnings call for Kindred Biosciences will take place at 4:30 p.m. Eastern Time on November 9, 2020.

How can I access the Kindred Biosciences conference call?

You can access the conference call by dialing (855) 433-0927 in the U.S. or (484) 756-4262 internationally using conference ID 5758359.

What is Kindred Biosciences' focus as a biopharmaceutical company?

Kindred Biosciences focuses on developing safe and effective medicines for pets, utilizing proven human-target therapies.